Project Name: Greater Manchester Cancer Care Alliance -Cancer Care Coordinators within Breast Oncology services

Project Summary:

The Collaborative Working Project (“CWP”) aims to maximise efficiency to optimise workforce capacity within the Greater Manchester (“GM”) breast cancer (“BC”) oncology service with the creation of a new  dedicated workforce role of four Breast cancer care coordinators for two years. The intention is to maximise efficiency of clinical appointments that will improve the pathway for patients providing a more efficient and co-ordinated approach to their care.

Planned Milestones:

Milestone

Description

1

Kick off meeting 

2

Project lead to work up the job spec, protocols, workflow and recruitment of the cancer care 
coordinators and Project Manager

3

Confirmation of the 4 Breast Cancer care coordinators employment of; on-boarding and familiarisation; 
complete collection of baseline aggregate comparator data for the project outcomes as detailed above by the Christie

Implement in-patient strategies/protocols and procedures governing the clinical operations of the Breast Cancer Service. 
Begin clinical operations according to the developed protocols, monitor and collect data.  

4

Novartis SIM to conduct Reimagining Care Pathways for the GM SACT delivery service which is provided by the 
Christie oncology team

5

Carry out 3 months of clinical operations according to the developed protocols, The Christie to monitor and collect data, 
provide anonymised report containing such data to Novartis to assess against milestone, as applicable, as per the 
measurement criteria outlined in the “Project Outcomes and Measurement Criteria” section above.   

6

Carry out 6 months of clinical operations according to the developed protocols, The Christie to monitor and collect data, 
provide anonymised report containing such data to Novartis to assess against milestone, as applicable, as per the 
measurement criteria outlined in the “Project Outcomes and Measurement Criteria” section above.   

7

Project Manager to Network with the other 20 Cancer Care alliances to share the interim outputs of the service redesign

8

Carry out 9 months of clinical operations according to the developed protocols, The Christie to monitor and collect data, 
provide anonymised report containing such data to Novartis to assess against milestone, as applicable, as per the 
measurement criteria outlined in the “Project Outcomes and Measurement Criteria” section above.   

9

Carry out 12 months of clinical operations according to the developed protocols, The Christie to monitor and collect data, 
provide anonymised report containing such data to Novartis to assess against milestone, as applicable, as per the 
measurement criteria outlined in the “Project Outcomes and Measurement Criteria” section above.  

10

Carry out 15 months of clinical operations according to the developed protocols, The Christie to monitor and collect data, 
provide anonymised report containing such data to Novartis to assess against milestone, as applicable, as per the 
measurement criteria outlined in the “Project Outcomes and Measurement Criteria” section above.   

11

Carry out 18 months of clinical operations according to the developed protocols, The Christie  to monitor and collect data, 
provide anonymised report containing such data to Novartis to assess against milestone, as applicable, as per the 
measurement criteria outlined in the “Project Outcomes and Measurement Criteria” section above 

12

Carry out 21 months of clinical operations according to the developed protocols, The Christie to monitor and collect data, 
provide anonymised report containing such data to Novartis to assess against milestone, as applicable, as per the 
measurement criteria outlined in the “Project Outcomes and Measurement Criteria” section above.   

13

Carry out 24 months of clinical operations according to the developed protocols, The Christie to monitor and collect data, 
provide anonymised report containing such data to Novartis to assess against milestone, as applicable, as per the 
measurement criteria outlined in the “Project Outcomes and Measurement Criteria” section above 

14

Develop business case to support future funding by the The Christie to continue with the service. Submit final CWP 
report to Novartis

Develop with Novartis within 2 months from completion of the clinical work for outcomes publishing in line with the 
ABPI guidelines

 

Expected Benefits:

ANTICIPATED BENEFITS FOR PATIENTS

  • Named nurse co-ordinating BC care will improve patient experience of the BC service by coordinating the patients Cancer care appointments
  • More streamlined pathway to improve the patient experience and limit visits to the hospital

ANTICIPATED BENEFITS FOR THE ORGANISATION(S)

  • Workforce efficiency and optimisation by removing administrative burden from clinical staff and coordinating patient care
  • Increased clinic efficiency by ensuring all up to date tests results are available at the right time
  • Increase the overall quality of care and improve equity of access to specialist care for patients with BC requiring treatment initiation, evaluation, and monitoring
  • Provide a single point of contact for patients, thereby reducing the potential for unplanned calls being received by the wider clinical team
  • Free up consultant capacity for clinical activities that are unique to their skillset
  • CWP would highlight GM cancer Care Alliance and The Christies  as an exemplar in service re-design of worksforce optimisation and sustainability

ANTICIPATED BENEFITS FOR NOVARTIS

  • Better understanding of overall HCP and patient needs
  • Optimal use of medicines in line with local/national guidance (including Novartis medicines) in appropriate patients
  • Ethical, professional, and transparent relationship between Novartis and the Healthcare Organisations

Start Date & Duration: October 2023 for 32 months

UK2310115503